forward-looking 2 - The Latremie Post

Corsair Gaming, Inc. (CRSR) Q3 2025 Earnings Call Transcript

Operator: Ladies and gentlemen, good afternoon, and welcome to Corsair Gaming’s Third Quarter 2025 Earnings Conference Call. As a reminder, today’s call is being recorded, and your participation implies consent to such recording.

[Operator Instructions]

With that, I would now like to turn the call over to David Pasquale with Corsair Investor Relations. Thank you. Sir, please begin.

—

**David Pasquale:**
Thank you, operator. Good afternoon, everyone, and thank you for joining us for Corsair’s Financial Results Conference Call for the third quarter ended September 30, 2025.

On the call today, we have Corsair’s CEO, Thi La, and CFO, Michael Potter. Thi will review highlights from the quarter. Michael will then review the financials and our outlook. Afterward, we will have time for any questions.

Before we begin, allow me to provide a disclaimer regarding forward-looking statements. This call, including the Q&A portion, may include forward-looking statements related to the expected future results for our company and are, therefore, forward-looking statements.

Our actual results may differ materially from our projections due to a number of risks and uncertainties. The risks and uncertainties that forward-looking statements are subject to are described in our earnings release and other SEC filings.

Please note that until our 10-Q has been filed, these numbers are preliminary.

Today’s remarks will also include references to non-GAAP financial measures. Additional information, including reconciliation between non-GAAP financial information and GAAP financial information, is provided in the press release we issued.

—

We look forward to sharing more details on the quarter and engaging with your questions shortly.
https://seekingalpha.com/article/4837926-corsair-gaming-inc-crsr-q3-2025-earnings-call-transcript?source=feed_all_articles

Safilo Group S.p.A. (SAFLY) Q3 2025 Sales Call Transcript

**Safilo Group Third Quarter and First 9 Months 2025 Trading Update**

*Operator:*
Good evening, and welcome to the Safilo Group Third Quarter and First 9 Months 2025 Trading Update. This call may contain forward-looking statements related to future events and operating, economic, and financial results for the Safilo Group. Such forecasts, due to their nature, imply a component of risk and uncertainty because they depend on the occurrence of certain future events and developments. The actual results may therefore vary, even significantly, from those announced due to a multitude of factors.

Today’s participants are:
– Mr. Angelo Trocchia, Chief Executive Officer
– Mr. Michele Melotti, Chief Financial Officer
– Ms. Barbara Ferrante, Director of Investor Relations

I will now pass the call over to Mr. Angelo Trocchia, Chief Executive Officer. Mr. Trocchia, you may begin, sir.

—

**Angelo Trocchia, CEO & Director:**
Thanks very much. Good evening, everyone, and thank you for joining us today to discuss Safilo’s trading update for the third quarter and the first nine months of 2025.

Let me start by saying that Q3 was another solid quarter for Safilo. We stayed on course, delivering a consistent performance, marked by steady sales growth at constant exchange rates, further margin improvement, and another round of robust cash flow generation.

In the context of persistent macroeconomic uncertainty and tariff pressures, these results give us even greater confidence in our ability to navigate successfully moving forward.
https://seekingalpha.com/article/4837884-safilo-group-s-p-a-safly-q3-2025-sales-call-transcript?source=feed_all_articles

Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call Transcript

Operator: Good day, everyone, and thank you for standing by. My name is RJ, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q3 2025 Xenon Pharmaceuticals, Inc. Earnings Conference Call.

[Operator Instructions]

I would now like to turn the call over to Colleen, Senior— or Xenon Senior Vice President of Corporate Affairs. Please go ahead.

—

**Colleen Alabiso:**
Good afternoon. Thank you for joining us on our call and webcast to discuss Xenon’s third quarter 2025 financial and operating results.

Joining me today are Ian Mortimer, President and Chief Executive Officer; Dr. Chris Kenney, Chief Medical Officer; Darren Cline, Chief Commercial Officer; and Tucker Kelly, our Chief Financial Officer.

After completing our prepared remarks today, we will open the call up for questions.

Please be advised that during this call, we will make a number of forward-looking statements. These include statements regarding the timing of and potential results from clinical trials, the potential efficacy and safety profile of our products, future development plans, current and anticipated indications, addressable markets, regulatory success, and the commercial potential of our and our partners’ product candidates.

We will also discuss the efficacy of our clinical trial designs and our ability to successfully develop and…
https://seekingalpha.com/article/4837165-xenon-pharmaceuticals-inc-xene-q3-2025-earnings-call-transcript?source=feed_all_articles

Range Resources Corporation (RRC) Q3 2025 Earnings Call Transcript

Operator: Good day. Welcome to the Range Resources Third Quarter 2025 Earnings Conference Call. [Operator Instructions]

Statements made during this conference call that are not historical facts are forward-looking statements. Such statements are subject to risks and uncertainties, which could cause actual results to differ materially from those in the forward-looking statements.

After the speaker’s remarks, there will be a question-and-answer period. At this time, I would like to turn the call over to Mr. Laith Sando, SVP, Investor Relations at Range Resources. Please go ahead, sir.

—

**Laith Sando**
Senior Vice President of Corporate Strategy & Investor Relations

Thank you, operator. Good morning, everyone, and thank you for joining Range’s Third Quarter 2025 Earnings Call. With me on the call today are Dennis Degner, Chief Executive Officer; and Mark Scucchi, Chief Financial Officer.

I hope you’ve had a chance to review the press release and the updated investor presentation that we posted on our website. We may reference certain slides during the call this morning.

You’ll also find our 10-Q filing on Range’s website under the Investors tab or can access it using the SEC’s EDGAR system.

Please note, we will be referencing certain non-GAAP measures during today’s call.
https://seekingalpha.com/article/4834740-range-resources-corporation-rrc-q3-2025-earnings-call-transcript?source=feed_all_articles

Ryerson Holding Corporation (RYI) Q3 2025 Earnings Call Transcript

Justine Carlson
Good morning. Thank you for joining Ryerson Holding Corporation’s Third Quarter 2025 Earnings Call.

On our call, we have Eddie Lehner, Ryerson’s President and Chief Executive Officer; Jim Claussen, our Chief Financial Officer; and Molly Kannan, our Chief Accounting Officer and Corporate Controller.

A recording of this call will be posted on our Investor Relations website at ir.ryerson.com.

Please read the forward-looking statement disclosures included in our earnings release issued yesterday and note that they apply to all statements made during this call. In addition, our remarks today refer to several non-GAAP measures. Reconciliations of these adjusted numbers are also included in our earnings release.

I’ll now turn the call over to Eddie.

**Edward Lehner**
*President, CEO & Director*

Thank you, Justine. Good morning, and thank you all for joining us to discuss our third quarter 2025 performance and our announced merger agreement with Olympic Steel.
https://seekingalpha.com/article/4834900-ryerson-holding-corporation-ryi-q3-2025-earnings-call-transcript?source=feed_all_articles

United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call Transcript

Operator: Good morning, everyone, and welcome to the United Therapeutics Corporation Third Quarter 2025 Corporate Update. My name is Jamie, and I will be your conference operator today.

[Operator Instructions]

Please also note today’s event is being recorded. At this time, I’d like to turn the floor over to Harry Silvers, Investor Relations Manager at United Therapeutics.

—

**Harrison Silvers, Manager of Investor Relations:**

Thank you, Jamie. Good morning. It is my pleasure to welcome you to the United Therapeutics Corporation Third Quarter 2025 Corporate Update Webcast.

Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially.

Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties. We assume no obligation to update forward-looking statements.

Today’s remarks may also discuss the progress and results of clinical trials or other developments with respect to our products. These remarks are intended solely to educate investors and are not intended to serve as the basis for medical decision-making or to suggest that any products are safe and effective for any unapproved or investigational uses.

Full prescribing information for the products is available upon request.
https://seekingalpha.com/article/4834678-united-therapeutics-corporation-uthr-q3-2025-earnings-call-transcript?source=feed_all_articles

Regions Financial Corporation (RF) Q3 2025 Earnings Call Transcript

Operator: Good morning, and welcome to the Regions Financial Corporation’s quarterly earnings call. My name is Chris, and I will be your operator for today’s call. [Operator Instructions] I will now turn the call over to Dana Nolan to begin.

**Dana Nolan**
EVP & Head of Investor Relations

Thank you, Chris. Welcome to Regions’ Third Quarter earnings call. John and David will provide high-level commentary regarding our results. Earnings documents, which include our forward-looking statement disclaimer and non-GAAP reconciliations, are available in the Investor Relations section of our website. These disclosures cover our presentation materials, today’s prepared remarks, and Q&A.

I will now turn the call over to John.

**John Turner**
President, CEO & Chairman

Thank you, Dana, and good morning, everyone. We appreciate you joining our call today.

Earlier this morning, we reported strong quarterly earnings of $548 million, resulting in earnings per share of $0.61. On an adjusted basis, earnings were $561 million or $0.63 per share.

We delivered adjusted pretax pre-provision income of $830 million, a 4% increase year-over-year, and we generated a strong return on tangible common equity of 19%. We…
https://seekingalpha.com/article/4830817-regions-financial-corporation-rf-q3-2025-earnings-call-transcript?source=feed_all_articles